Total Payments
$209,690
2024 Payments
$48,684
Companies
51
Transactions
1,770
Medicare Patients
12,791
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$165,863 (79.1%)
Food & Beverage$33,512 (16.0%)
Consulting$5,763 (2.7%)
Travel$4,136 (2.0%)
Education$416.31 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $165,063 | 80 | 78.7% |
| Food and Beverage | $33,512 | 1,659 | 16.0% |
| Consulting Fee | $5,763 | 4 | 2.7% |
| Travel and Lodging | $4,136 | 18 | 2.0% |
| Honoraria | $800.00 | 1 | 0.4% |
| Education | $416.31 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $121,943 | 369 | $0 (2024) |
| Lilly USA, LLC | $56,705 | 151 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $5,131 | 70 | $0 (2024) |
| Janssen Biotech, Inc. | $3,966 | 161 | $0 (2024) |
| PFIZER INC. | $3,248 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,092 | 102 | $0 (2024) |
| GENZYME CORPORATION | $1,906 | 75 | $0 (2024) |
| Amgen Inc. | $1,817 | 80 | $0 (2024) |
| Celgene Corporation | $1,774 | 65 | $0 (2019) |
| Arcutis Biotherapeutics, Inc. | $1,731 | 57 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,684 | 332 | ABBVIE INC. ($33,107) |
| 2023 | $69,896 | 346 | AbbVie Inc. ($48,694) |
| 2022 | $54,774 | 263 | ABBVIE INC. ($34,584) |
| 2021 | $25,518 | 228 | Lilly USA, LLC ($17,726) |
| 2020 | $3,051 | 148 | AbbVie Inc. ($514.79) |
| 2019 | $2,669 | 154 | AbbVie, Inc. ($571.64) |
| 2018 | $2,585 | 163 | Encore Dermatology Inc. ($325.22) |
| 2017 | $2,513 | 136 | Celgene Corporation ($904.01) |
All Payment Transactions
1,770 individual payment records from CMS Open Payments — Page 1 of 71
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $33.08 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Immunology | ||||||
| 12/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Inflammation & Immunology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $39.21 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $5.93 | General |
| 12/02/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $1.69 | General |
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Immunology | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 3,746 | 7,968 | $1.8M | $361,853 |
| 2022 | 29 | 3,510 | 7,184 | $1.6M | $324,638 |
| 2021 | 25 | 2,917 | 6,277 | $1.3M | $278,490 |
| 2020 | 26 | 2,618 | 5,587 | $777,146 | $213,608 |
Total Patients
12,791
Total Services
27,016
Medicare Billing
$1.2M
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 798 | 1,319 | $391,743 | $81,498 | 20.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 524 | 687 | $232,206 | $51,045 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 317 | 538 | $225,960 | $48,347 | 21.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 525 | 789 | $175,947 | $31,454 | 17.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 85 | 93 | $94,023 | $21,664 | 23.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 428 | 3,106 | $71,438 | $15,980 | 22.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 186 | 340 | $57,120 | $13,689 | 24.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 74 | 92 | $54,648 | $11,361 | 20.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 163 | 163 | $60,147 | $11,282 | 18.8% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 49 | 52 | $45,656 | $10,700 | 23.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 67 | 71 | $57,723 | $7,127 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $30,632 | $6,561 | 21.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 45 | 49 | $27,538 | $6,192 | 22.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 12 | 19 | $24,225 | $5,822 | 24.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 54 | 68 | $25,704 | $5,578 | 21.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 15 | 16 | $16,496 | $3,766 | 22.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 29 | 38 | $18,696 | $3,249 | 17.4% |
| 12041 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.5 cm or less | Office | 2023 | 12 | 14 | $12,334 | $3,000 | 24.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 70 | $13,020 | $2,960 | 22.7% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 11 | 12 | $11,352 | $2,688 | 23.7% |
| 69100 | Biopsy of ear | Office | 2023 | 42 | 46 | $14,766 | $2,540 | 17.2% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 15 | 18 | $11,286 | $2,443 | 21.6% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 16 | 16 | $10,256 | $2,343 | 22.8% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 17 | 21 | $17,619 | $2,248 | 12.8% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 21 | 21 | $19,467 | $2,174 | 11.2% |
About Dr. Daniel Walker, MD
Dr. Daniel Walker, MD is a Dermatology healthcare provider based in Grapevine, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2012. The National Provider Identifier (NPI) number assigned to this provider is 1669731519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Walker, MD has received a total of $209,690 in payments from pharmaceutical and medical device companies, with $48,684 received in 2024. These payments were reported across 1,770 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($165,063).
As a Medicare-enrolled provider, Walker has provided services to 12,791 Medicare beneficiaries, totaling 27,016 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Grapevine, TX
- Active Since 05/14/2012
- Last Updated 07/21/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669731519
Products in Payments
- RINVOQ (Biological) $65,201
- SKYRIZI (Biological) $55,336
- TALTZ (Drug) $50,388
- ILUMYA (Biological) $3,561
- Otezla (Drug) $3,547
- TREMFYA (Drug) $2,989
- CIBINQO (Drug) $2,615
- DUPIXENT (Biological) $2,552
- COSENTYX (Biological) $1,302
- Zoryve (Drug) $1,211
- Odomzo (Drug) $800.00
- Cimzia (Drug) $746.15
- EUCRISA (Drug) $632.98
- DORYX (Drug) $614.21
- COSENTYX (Drug) $600.34
- Humira (Biological) $597.90
- OPZELURA (Drug) $566.99
- VTAMA (Drug) $547.48
- SILIQ (Drug) $536.20
- REMICADE (Biological) $468.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.